文献速递心力衰竭与心肌病冠心病

IL-33通过作用于心肌细胞介导急性肾损伤后的心肌病

Interleukin-33 Mediates Cardiomyopathy After Acute Kidney Injury by Signaling to Cardiomyocytes.
PubMed 文献 · Circulation · 2023-01-25

该研究利用缺血再灌注急性肾损伤(AKI)和单侧输尿管梗阻小鼠模型,探究IL-33及其受体基因Il1rl1(ST2L)在AKI后心脏重构中的作用。结果显示,Il33缺陷小鼠对两种肾损伤相关的心肌病具有抵抗性,IL-33抗体治疗可保护心脏,而IL-33过表达或重组IL-33诱导心肌肥厚或心肌病依赖于Il1rl1。心肌细胞特异性删除Il1rl1可减轻AKI诱导的心肌病,提示IL-33/ST2轴拮抗剂可能对肾病患者具有心脏保护作用。

要点

  • AKI时肾脏释放的IL-33通过直接作用于心肌细胞ST2L介导心肾综合征。
  • 阻断IL-33/ST2轴可减轻AKI后的心脏重构和心肌病。
  • 心肌细胞而非内皮细胞或成纤维细胞的Il1rl1缺失具有心脏保护作用。

核心结论

  • AKI时肾脏释放的IL-33通过直接信号传导至心肌细胞,是心肾综合征的基础,提示拮抗IL-33/ST2轴可能对肾病患者具有心脏保护作用。

研究设计与样本

  • 研究使用小鼠缺血再灌注AKI模型和单侧输尿管梗阻模型,以及细胞类型特异性基因敲除小鼠、IL-33单克隆抗体、腺相关病毒编码IL-33或ST2L和重组IL-33。

主要发现

  • Il33缺陷小鼠对两种肾损伤模型相关的心肌病具有抵抗性。
  • 使用IL-33单克隆抗体治疗可保护AKI后的心脏。
  • 过表达IL-33或注射重组IL-33诱导心脏肥厚或心肌病,但在缺乏Il1rl1的小鼠中不发生。
  • 心肌细胞特异性删除Il1rl1可减轻AKI诱导的心肌病,而内皮细胞或成纤维细胞特异性删除Il1rl1则不能。
  • 在心肌细胞中过表达ST2L受体可重现心脏肥厚的诱导。

临床怎么用

  • 对于AKI患者,拮抗IL-33/ST2轴可能成为预防或减轻心肾综合征心脏并发症的策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acute kidney injury (AKI) is a short-term life-threatening condition that, if survived, can lead to renal insufficiency and development of chronic kidney disease. The pathogenesis of AKI and chronic kidney disease involves direct effects on the heart and the development of hypertrophy and cardiomyopathy. METHODS: We used mouse models of ischemia/reperfusion AKI and unilateral ureteral obstruction to investigate the role of IL-33 (interleukin-33) and its receptor-encoding gene Il1rl1 (also called ST2L [suppression of tumorigenicity 2]) in cardiac remodeling after AKI. Mice with cell type-specific genetic disruption of the IL-33/ST2L axis were used, and IL-33 monoclonal antibody, adeno-associated virus encoding IL-33 or ST2L, and recombinant IL-33, as well. RESULTS: Mice deficient in Il33 were refractory to cardiomyopathy associated with 2 models of kidney injury. Treatment of mice with monoclonal IL-33 antibody also protected the heart after AKI. Moreover, overexpression of IL-33 or injection of recombinant IL-33 induced cardiac hypertrophy or cardiomyopathy, but not in mice lacking Il1rl1. AKI-induced cardiomyopathy was also reduced in mice with cardiac myocyte-specific deletion of Il1rl1 but not in endothelial cell- or fibroblast-specific deletion of Il1rl1. Last, overexpression of the ST2L receptor in cardiac myocytes recapitulated induction of cardiac hypertrophy. CONCLUSIONS: These results indicate that IL-33 released from the kidney during AKI underlies cardiorenal syndrome by directly signaling to cardiac myocytes, suggesting that antagonism of IL-33/ST2 axis would be cardioprotective in patients with kidney disease.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Florens N, Kasam RK, Rudman-Melnick V, et al. Interleukin-33 Mediates Cardiomyopathy After Acute Kidney Injury by Signaling to Cardiomyocytes. Circulation. 2023. PMID: 36695175. doi:10.1161/CIRCULATIONAHA.122.063014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。